A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

Hs0006 50175, Phoenix, Arizona, United States

Hs0006 50708, Roseville, California, United States

Hs0006 50684, Sacramento, California, United States

Hs0006 50707, Washington D.C., District of Columbia, United States

Hs0006 50199, Miami, Florida, United States

Hs0006 50712, Bowling Green, Kentucky, United States

Hs0006 50178, Clarkston, Michigan, United States

Hs0006 50710, Fort Gratiot, Michigan, United States

Hs0006 50711, Troy, Michigan, United States

Hs0006 50706, Chapel Hill, North Carolina, United States

Hs0006 50202, Fairborn, Ohio, United States

Hs0006 50201, Arlington, Texas, United States

Hs0006 40326, Berlin, Germany

Hs0006 40747, Mainz, Germany

Hs0006 40625, Lodz, Poland

Hs0006 40761, Warsaw, Poland

Hs0006 40095, Wroclaw, Poland

Hs0006 40845, Wroclaw, Poland